ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,298.55
0.03%
Dow Jones
39,893.52
0.06%
US Dollar vs MXN
16.61691
-0.38%
Brent Oil
83.37
0.20%
Bitcoin
67,114.01
2.87%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. TSX
  6. Aeterna Zentaris Inc (AEZS)

  7. Aeterna Zentaris Inc (AEZS) Noticias

AEZS

Aeterna Zentaris (AEZS)

Aeterna Zentaris Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:TSX:AEZS
FechaHoraFuenteTítuloSímboloCompañía
14/12/202307:18PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - AEZSTSX:AEZSAeterna Zentaris Inc
14/12/202307:16PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - AEZSTSX:AEZSAeterna Zentaris Inc
14/12/202307:14PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - AEZSTSX:AEZSAeterna Zentaris Inc
14/12/202307:12PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - AEZSTSX:AEZSAeterna Zentaris Inc
13/03/201906:53PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - AEZSTSX:AEZSAeterna Zentaris Inc
13/03/201906:52PR Newswire (Canada)IIROC Trade Resumption - AEZSTSX:AEZSAeterna Zentaris Inc
12/03/201914:32PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - AEZSTSX:AEZSAeterna Zentaris Inc
12/03/201914:27PR Newswire (Canada)IIROC Trading Halt - AEZSTSX:AEZSAeterna Zentaris Inc
21/12/201707:26PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - AEZS; BNETSX:AEZSAeterna Zentaris Inc
21/12/201707:23PR Newswire (Canada)IIROC Trade Resumption - AEZS; BNETSX:AEZSAeterna Zentaris Inc
03/02/201007:35PR Newswire (US)AEterna Zentaris Partner Keryx Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of Perifosine (KRX-040NASDAQ:AEZS
29/01/201007:35PR Newswire (US)AEterna Zentaris Partner Keryx Announces Positive Phase 2 Results for Perifosine as a Single Agent for the Treatment of AdvancedNASDAQ:AEZS
29/01/201007:30PR Newswire (US)Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results of Perifosine as a Single Agent for the Treatment of Advanced NASDAQ:AEZS
27/01/201015:00PR Newswire (US)Keryx Biopharmaceuticals, Inc. to Conduct Conference Call to Discuss KRX-0401 (Perifosine) Clinical Development Program in ColorNASDAQ:AEZS
25/01/201007:35PR Newswire (US)AEterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, DouNASDAQ:AEZS
25/01/201007:30PR Newswire (US)Keryx Reports Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-ControllNASDAQ:AEZS
22/01/201015:05PR Newswire (US)AEterna Zentaris Receives NASDAQ Notification Related to Minimum Bid PriceNASDAQ:AEZS
21/01/201007:35PR Newswire (US)AEterna Zentaris Partner, Keryx Biopharmaceuticals, to Present Poster Highlighting Clinical Activity of Perifosine (KRX-0401) atNASDAQ:AEZS
21/01/201007:30PR Newswire (US)Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the ASCO 2010 NASDAQ:AEZS
18/12/200906:15PR Newswire (US)AEterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and LicensinNASDAQ:AEZS
16/12/200907:35PR Newswire (US)AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients wNASDAQ:AEZS
09/12/200906:30PR Newswire (US)AEterna Zentaris Announces Appointment of New Board MemberNASDAQ:AEZS
07/12/200907:35PR Newswire (US)AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the TrNASDAQ:AEZS
07/12/200907:30PR Newswire (US)Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the TreaNASDAQ:AEZS
07/12/200906:40PR Newswire (US)AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic HyperplasiaNASDAQ:AEZS
02/12/200907:35PR Newswire (US)AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of RelapsedNASDAQ:AEZS
02/12/200907:30PR Newswire (US)Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple MyelomaNASDAQ:AEZS
24/11/200906:00PR Newswire (US)AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in EndomeNASDAQ:AEZS
11/11/200907:35PR Newswire (US)AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (NASDAQ:AEZS
11/11/200907:30PR Newswire (US)Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st AnnuaNASDAQ:AEZS
 Showing the most relevant articles for your search:TSX:AEZS

Su Consulta Reciente

NYSE
JPM
JP Morgan Chase
AMEX
XLV
Health Care Select Sector
NYSE
XOM
Exxon Mobil
NYSE
KO
Coca Cola
NYSE
DIS
Walt Disney
FX
USDMXN
US Dollar vs MXN
USOTC
BASFY
BASF (QX)
NYSE
MCD
McDonalds
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
ETHUSD
Ethereum
NASDAQ
TSLA
Tesla
CCOM
SILVER
SILVER
NASDAQ
AMZN
Amazon.com
FX
EURMXN
Euro vs MXN
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados